2016


Nierat, M.C., et al., When Breathing Interferes with Cognition: Experimental Inspiratory Loading Alters Timed Up-and-Go Test in Normal Humans. PLoS One, 2016. 11(3): p. e0151625.


O'Donnell, D.E., et al., Chronic breathlessness in patients with idiopathic pulmonary fibrosis: a major challenge for caregivers. Expert Rev Respir Med, 2016. 10(12): p. 1295-1303.


Britton, D., J.O. Benditt, and J.D. Hoit, Beyond Tracheostomy: Noninvasive Ventilation and Potential Positive Implications for Speaking and Swallowing. Semin Speech Lang, 2016. 37(3): p. 173-84.


O'Donnell, D.E., et al., Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing. Eur Respir Rev, 2016. 25(141): p. 333-47.


Mahler, D.A., et al., Efficacy of Indacaterol/Glycopyrronium in Patients with COPD Who Have Increased Dyspnea with Daily Activities. Chronic Obstr Pulm Dis, 2016. 3(4): p. 758-768.


Giuliani, M.E., et al., The prevalence and nature of supportive care needs in lung cancer patients. Curr Oncol, 2016. 23(4): p. 258-65.


Ferreira, D.H., et al., Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness--An Exploratory Study. J Pain Symptom Manage, 2016. 51(2): p. 247-54.


Currow, D.C., et al., The need to research refractory breathlessness. Eur Respir J, 2016. 47(1): p. 342-3.


Watts, G.J., et al., Study protocol: a phase III randomised, double-blind, parallel arm, stratified, block randomised, placebo-controlled trial investigating the clinical effect and cost-effectiveness of sertraline for the palliative relief of breathlessness in people with chronic breathlessness. BMJ Open, 2016. 6(11): p. e013177.


Smith, A.K., et al., Prevalence and Outcomes of Breathlessness in Older Adults: A National Population Study. J Am Geriatr Soc, 2016. 64(10): p. 2035-2041.


Nipp, R.D., et al., Identifying cancer patients who alter care or lifestyle due to treatment-related financial distress. Psychooncology, 2016. 25(6): p. 719-25.


Martins, R.T., et al., Effects of low-dose morphine on perceived sleep quality in patients with refractory breathlessness: A hypothesis generating study. Respirology, 2016. 21(2): p. 386-91.


Hanif, M.F., B. Iqbal, and N. Gilani, Cortical venous infarcts and acute limb ischaemia in acute carbon monoxide poisoning: A rare case report. J Pak Med Assoc, 2016. 66(6): p. 771-3.


Stevens, J.P., et al., Prevalence and Predictive Value of Dyspnea Ratings in Hospitalized Patients: Pilot Studies. PLoS One, 2016. 11(4): p. e0152601.


Banerji, D., D.A. Mahler, and N.A. Hanania, Efficacy and safety of LABA/LAMA fixed-dose combinations approved in the US for the management of COPD. Expert Rev Respir Med, 2016. 10(7): p. 767-80.


Lauren, S.T., S.O. Simons, and A.I. Arens, [A man with slowly progressive dyspnea on exertion]. Ned Tijdschr Geneeskd, 2016. 160: p. D426.


Esser, R.W., et al., Structural Brain Changes in Patients With COPD. Chest, 2016. 149(2): p. 426-34.


O'Donnell, D.E., et al., Pharmacological management of breathlessness in COPD: recent advances and hopes for the future. Expert Rev Respir Med, 2016. 10(7): p. 823-34.


Nierat, M.C., et al., When Breathing Interferes with Cognition: Experimental Inspiratory Loading Alters Timed Up-and-Go Test in Normal Humans. PLoS One, 2016. 11(3): p. e0151625.

2015


Banzett, R.B., et al., Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research. Eur Respir J, 2015. 45(6): p. 1681-91.


Wysham, N.G., et al., Practical Dyspnea Assessment: Relationship Between the 0-10 Numerical Rating Scale and the Four-Level Categorical Verbal Descriptor Scale of Dyspnea Intensity. J Pain Symptom Manage, 2015. 50(4): p. 480-7.


Ekstrom, M., et al., Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ann Am Thorac Soc, 2015. 12(7): p. 1079-92.


LeBlanc, T.W., et al., What bothers lung cancer patients the most? A prospective, longitudinal electronic patient-reported outcomes study in advanced non-small cell lung cancer. Support Care Cancer, 2015. 23(12): p. 3455-63.


Kamal, A.H., et al., Symptom Burden and Performance Status among Community-Dwelling Patients with Serious Illness. J Palliat Med, 2015. 18(6): p. 542-4.


Ekstrom, M.P., A.P. Abernethy, and D.C. Currow, The management of chronic breathlessness in patients with advanced and terminal illness. BMJ, 2015. 349: p. g7617.


Uronis, H.E., et al., Oxygen for relief of dyspnoea in people with chronic obstructive pulmonary disease who would not qualify for home oxygen: a systematic review and meta-analysis. Thorax, 2015. 70(5): p. 492-4.


Schroijen, M., et al., Generalization of Fear to Respiratory Sensations. Behav Ther, 2015. 46(5): p. 611-26.


Pappens, M., et al., Interoceptive fear learning to mild breathlessness as a laboratory model for unexpected panic attacks. Front Psychol, 2015. 6: p. 1150.


Kassardjian, C.D., et al., Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy. JAMA Neurol, 2015. 72(9): p. 996-1003.


Mahler, D.A., et al., FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med, 2015. 192(9): p. 1068-79.


Mahler, D.A., et al., Indacaterol vs tiotropium in COPD patients classified as GOLD A and B. Respir Med, 2015. 109(8): p. 1031-9.


Chang, A.S., et al., Prospective use of descriptors of dyspnea to diagnose common respiratory diseases. Chest, 2015. 148(4): p. 895-902.


Mahler, D.A. and D.E. O'Donnell, Recent advances in dyspnea. Chest, 2015. 147(1): p. 232-41.


Herigstad, M., et al., Dyspnea-related cues engage the prefrontal cortex: evidence from functional brain imaging in COPD. Chest, 2015. 148(4): p. 953-61.


Banzett, R.B. and R.M. Schwartzstein, Dyspnea: Don't Just Look, Ask! Am J Respir Crit Care Med, 2015. 192(12): p. 1404-6.


Banzett, R.B., et al., Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research. Eur Respir J, 2015. 45(6): p. 1681-91.


Santos, C., et al., Pulmonary Rehabilitation in COPD: Effect of 2 Aerobic Exercise Intensities on Subject-Centered Outcomes--A Randomized Controlled Trial. Respir Care, 2015. 60(11): p. 1603-9.


Donesky, D., Management of acute breathlessness in the person with chronic refractory breathlessness. Curr Opin Support Palliat Care, 2015. 9(3): p. 212-6.


Yorke, J., et al., Management of the respiratory distress symptom cluster in lung cancer: a randomised controlled feasibility trial. Support Care Cancer, 2015. 23(11): p. 3373-84.

Publications

2017


Ibrahim, H., et al., Symptomatic Patent Foramen Ovale with Hemidiaphragm Paralysis. Case Rep Pulmonol, 2017. 2017: p. 9848696.


Allard, E., et al., Interferences between breathing, experimental dyspnoea and bodily self-consciousness. Sci Rep, 2017. 7(1): p. 9990.


Gutierrez, O., R. Michell, and D. Adler, Atrial myxoma: an unusual aetiology for exertional dyspnoea and palpitation. BMJ Case Rep, 2017. 2017.


Baker, K.M., S. DeSanto-Madeya, and R.B. Banzett, Routine dyspnea assessment and documentation: Nurses' experience yields wide acceptance. BMC Nurs, 2017. 16: p. 3.


Banzett, R.B. and S.H. Moosavi, Measuring dyspnoea: new multidimensional instruments to match our 21st century understanding. Eur Respir J, 2017. 49(3).


Soffler, M.I., et al., Treatment of Acute Dyspnea with Morphine to Avert Respiratory Failure. Ann Am Thorac Soc, 2017. 14(4): p. 584-588.


Donesky, D., et al., Evaluation of the Feasibility of a Home-Based TeleYoga Intervention in Participants with Both Chronic Obstructive Pulmonary Disease and Heart Failure. J Altern Complement Med, 2017. 23(9): p. 713-721.


Morelot-Panzini, C., et al., Breathlessness despite optimal pathophysiological treatment: on the relevance of being chronic. Eur Respir J, 2017. 50(3).


Gruenberger, J.B., et al., Greater dyspnea is associated with lower health-related quality of life among European patients with COPD. Int J Chron Obstruct Pulmon Dis, 2017. 12: p. 937-944.


Mahler, D.A., Evaluation of Dyspnea in the Elderly. Clin Geriatr Med, 2017. 33(4): p. 503-521.


Johnson, M.J., et al., Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness. Eur Respir J, 2017. 49(5).


Sanchez, O., et al., Pathophysiology of dyspnoea in acute pulmonary embolism: A cross-sectional evaluation. Respirology, 2017. 22(4): p. 771-777.


O'Donnell, C.R., et al., The Effect of Aerosol Saline on Laboratory-Induced Dyspnea. Lung, 2017. 195(1): p. 37-42.


Binks, A.P., S. Desjardin, and R. Riker, ICU Clinicians Underestimate Breathing Discomfort in Ventilated Subjects. Respir Care, 2017. 62(2): p. 150-155.


Laurens, S.T., S.O. Simons, and A.I. Arens, [A man with slowly progressive dyspnea on exertion]. Ned Tijdschr Geneeskd, 2016. 160: p. D426.


Esser, R.W., et al., Structural Brain Changes in Patients With COPD. Chest, 2016. 149(2): p. 426-434.


Spec, A., C.A. Santos, and M.A. Pence, Closing the Brief Case: Dyspnea in a Profoundly Immunocompromised Man. J Clin Microbiol, 2016. 54(10): p. 2628.


Spec, A., C.A. Santos, and M.A. Pence, The Brief Case: Dyspnea in a Profoundly Immunocompromised Man. J Clin Microbiol, 2016. 54(10): p. 2410-2.


2018


Banzett, R.B., et al., Aerosol furosemide for dyspnea: High-dose controlled delivery does not improve effectiveness. Respir Physiol Neurobiol, 2018. 247: p. 24-30.


Morelot-Panzini, C., et al., Aerosol furosemide for dyspnea: Controlled delivery does not improve effectiveness. Respir Physiol Neurobiol, 2018. 247: p. 146-155.


Stevens, J.P., et al., Prevalence of dyspnea among hospitalized patients at the time of admission. J Pain Symptom Manage, 2018.